Background: Renal replacement therapy has been suggested as a therapeutic option in the setting of acute right ventricular failure in patients with severe precapillary pulmonary hypertension. However, there are few data supporting this strategy. Objectives: To describe the clinical course and the prognosis of pulmonary hypertensive patients undergoing renal replacement therapy in the setting of acute right heart failure. Methods: This was a single-center retrospective study over an 11-year period. Data were collected from all patients with chronic precapillary pulmonary hypertension requiring catecholamine infusions for clinical worsening and acute kidney injury that necessitated renal replacement therapy. Results: Fourteen patients were included. At admission, patients had a blood urea of 28.2 mmol/l (22.3-41.2), a creatinine level of 496 µmol/l (304-590), and a mean urine output in the 24 h preceding hospitalization of 200 ml (0-650). Sixty-eight renal replacement therapy sessions were performed, 36 of which were continuous and 32 of which were intermittent. Systemic hypotension occurred in 16/32 intermittent and 16/36 continuous sessions (p = 0.9). Two patients died during a continuous session. The intensive care unit-related, 1-, and 3-month mortality was 46.7, 66.7, and 73.3%, respectively. Conclusion: Renal replacement therapy is feasible in the setting of acute right ventricular failure in patients with severe precapillary pulmonary hypertension but is associated with a poor prognosis. The best modality and timing in this population remain to be defined.

1.
Chin KM, Rubin LJ: Pulmonary arterial hypertension. J Am Coll Cardiol 2008;51:1527-1538.
2.
Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC), European Respiratory Society (ERS), International Society of Heart and Lung Transplantation (ISHLT), Galie N, Hoeper MM, Humbert M, et al: Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009;34:1219-1263.
3.
Sztrymf B, Humbert M: Practical management of pulmonary arterial hypertension in the intensive care unit; in Humbert M, Lynch JP 3rd (eds): Pulmonary Hypertension. New York, Informa Healthcare, 2009, pp 455-461.
4.
Sztrymf B, Souza R, Bertoletti L, et al: Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension. Eur Respir J 2010;35:1286-1293.
5.
Kurzyna M, Zyłkowska J, Fijałkowska A, et al: Characteristics and prognosis of patients with decompensated right ventricular failure during the course of pulmonary hypertension. Kardiol Pol 2008;66:1033-1039.
6.
Campo A, Mathai SC, Le Pavec J, et al: Outcomes of hospitalization for right heart failure in pulmonary arterial hypertension. Eur Respir J 2011;38:359-367.
7.
Haddad F, Fuh E, Peterson T, et al: Incidence, correlates, and consequences of acute kidney injury in patients with pulmonary arterial hypertension hospitalized with acute right-side heart failure. J Card Fail 2011;17:533-539.
8.
Shah SJ, Thenappan T, Rich S, Tian L, Archer SL, Gomberg-Maitland M: Association of serum creatinine with abnormal hemodynamics and mortality in pulmonary arterial hypertension. Circulation 2008;117:2475-2483.
9.
Lahm T, McCaslin CA, Wozniak TC, et al: Medical and surgical treatment of acute right ventricular failure. J Am Coll Cardiol 2010;56:1435-1446.
10.
Haddad F, Doyle R, Murphy DJ, Hunt SA: Right ventricular function in cardiovascular disease. 2. Pathophysiology, clinical importance, and management of right ventricular failure. Circulation 2008;117:1717-1731.
11.
Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative workgroup: Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8:R204-R212.
12.
Rabindranath K, Adams J, Macleod AM, Muirhead N: Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database Syst Rev 2007;3:CD003773.
13.
Pannu N, Klarenbach S, Wiebe N, Manns B, Tonelli M, Alberta Kidney Disease Network: Renal replacement therapy in patients with acute renal failure: a systematic review. JAMA 2008;299:793-805.
14.
Vinsonneau C, Camus C, Combes A, et al: Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet 2006;368:379-385.
15.
Carl DE, Grossman C, Behnke M, Sessler CN, Gehr TW: Effect of timing of dialysis on mortality in critically ill, septic patients with acute renal failure. Hemodial Int 2010;14:11-17.
16.
Shingarev R, Wille K, Tolwani A: Management of complications in renal replacement therapy. Semin Dial 2011;24:164-168.
17.
Liu KD, Himmelfarb J, Paganini E, et al: Timing of initiation of dialysis in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol 2006;1:915-919.
18.
Elseviers MM, Lins RL, Van der Niepen P, et al: Renal replacement therapy is an independent risk factor for mortality in critically ill patients with acute kidney injury. Crit Care 2010;14:R221.
19.
Dennen P, Douglas IS, Anderson R: Acute kidney injury in the intensive care unit: an update and primer for the intensivist. Crit Care Med 2010;38:261-275.
20.
Pedemonte VO, Aránguiz Santander E, Torres HH, et al: Right ventricular assistance with a centrifugal pump: report of two cases. Rev Med Chil 2008;136:359-366.
21.
Gregoric ID, Chandra D, Myers TJ, Scheinin SA, Loyalka P, Kar B: Extracorporeal membrane oxygenation as a bridge to emergency heart-lung transplantation in a patient with idiopathic pulmonary arterial hypertension. J Heart Lung Transplant 2008;27:466-468.
22.
Hoeper MM, Granton J: ICU management of patients with severe pulmonary hypertension and right heart failure. Am J Respir Crit Care Med 2011;184:1114-1124.
23.
Kielstein JT, Tolk S, Hafer C, et al: Effect of acute kidney injury requiring extended dialysis on 28 day and 1 year survival of patients undergoing interventional lung assist membrane ventilator treatment. BMC Nephrol 2011;12:15.
24.
Christie JD, Edwards LB, Kucheryavaya AY, et al: The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report - 2010. J Heart Lung Transplant 2010;29:1104-1118.
25.
Fadel E, Mercier O, Mussot S, et al: Long-term outcome of double-lung and heart-lung transplantation for pulmonary hypertension: a comparative retrospective study of 219 patients. Eur J Cardiothorac Surg 2010;38:277-284.
26.
Humbert M, Sitbon O, Chaouat A, et al: Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 2006;173:1023-1030.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.